“nash” Archives

in
Entry Author Date Location
Fatty Liver Disease Now Global, Terns Pharma Aims for NASH in China 04/04/18 San Francisco
Pursuing Larger Rivals, NGM Bio Tries To Make Mark On Fatty Livers 04/22/17 San Francisco
With $20M, UCSD Spinout Jecure To Press New Attack On NASH 02/15/17 San Diego
Acelity Sells LifeCell Tissue Repair Unit to Allergan for $2.9B 12/20/16 Texas
Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More 11/11/16 National
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
With Tobira Deal, Allergan Keeps Shopping For “Questionable” Assets 09/20/16 San Francisco
Intercept’s Liver Drug Wins FDA Approval To Treat Rare Disease 05/28/16 New York
West Coast Bio Roundup: Pfizer’s BBC Ghosts, Gilead’s NASH, HLI’s Cash 04/07/16 San Francisco
As Rivals Make News, Intercept Heads To Daylong Hearing For Liver Drug 04/06/16 New York
West Coast Bio Roundup: CRISPR Patent, HCV Data, Verily Digs & More 02/19/16 San Francisco
West Coast Bio Roundup: Google/Insel, SeaGen, Avalon, Alector & More 09/18/15 San Francisco
Well-Funded NGM Bio Nabs $200M To Boost Merck’s Metabolic Pipeline 02/23/15 San Francisco
Page 2 of 2 « previous page